We are live on !
Find out more
Delek Group Portfolio holdings
AUM
$2.59B
Turnover
32.94%
1-Year Est. Return
1.24%
This Fund
S&P 500
This Quarter Est. Return
+1.86%
1 Year Est. Return
-1.24%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.59B
AUM Growth
+$180M
(+7.5%)
Cap. Flow
-$12M
Cap. Flow % of AUM
Cap. Flow %
-0.46%
Top 10 Holdings %
Top 10 Hldgs %
27.3%
Holding
255
New
49
Increased
70
Reduced
72
Closed
35
Avg Time Held
Equity + Options
0.9
years
Top 10 Avg Time Held
Equity + Options
0.6
years
Top 20 Avg Time Held
Equity + Options
0.9
years
Avg Time Held Equity only
0.9
years
Top 10 Avg Time Held Equity only
0.6
years
Top 20 Avg Time Held Equity only
0.9
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Philip Morris
PM
|
+$28.1M |
| 2 |
iShares US Healthcare Providers ETF
IHF
|
+$28.1M |
| 3 |
Newmont
NEM
|
+$23.7M |
| 4 |
Freeport-McMoran
FCX
|
+$22.1M |
| 5 |
Trip.com Group
TCOM
|
+$22.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$50.7M |
| 2 |
International Flavors & Fragrances
IFF
|
+$43.1M |
| 3 |
Meta Platforms (Facebook)
META
|
+$25.2M |
| 4 |
Southern Copper
SCCO
|
+$19.3M |
| 5 |
MLNX
Mellanox Technologies, Ltd.
MLNX
|
+$17.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26% |
| 2 | Technology | 14.15% |
| 3 | Healthcare | 11.72% |
| 4 | Industrials | 9.3% |
| 5 | Materials | 8.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
201
DELISTED
Orgenesis Inc. Common Stock
ORGS
| $278K | 0.01% |
+6,400
| New | +$289K |
2019 Q2
0 quarters
|
|
202
WisdomTree Europe Hedged Equity Fund
HEDJ
$1.73B
| $251K | 0.01% |
7,772
-8,128
| -51% | -$267K |
2017 Q4
6 quarters
|
|
203
Kroger
KR
$37B
| $233K | 0.01% |
11,000
-399,667
| -97% | -$9.7M |
2017 Q4
6 quarters
|
|
|
DSPG
204
DELISTED
DSP Group Inc
DSPG
| $227K | 0.01% |
16,203
-3,211
| -17% | -$46.3K |
2019 Q1
1 quarter
|
|
|
NBL
205
CALL
DELISTED
Noble Energy, Inc.
NBL
| $224K | 0.01% |
+10,000
| New | +$237K |
2019 Q2
0 quarters
|
|
|
NBL
206
PUT
DELISTED
Noble Energy, Inc.
NBL
| $224K | 0.01% |
10,000
| – | – |
2017 Q4
6 quarters
|
|
207
Ceragon Networks
CRNT
$184M
| $178K | 0.01% |
62,180
+9,977
| +19% | +$32.6K |
2019 Q1
1 quarter
|
|
208
Eocene Ltd. Ordinary Shares
EOCN
$3.08M
| $176K | 0.01% |
17
+2
| +13% | +$20.6K |
2019 Q1
1 quarter
|
|
209
Opko Health
OPK
$1.27B
| $174K | 0.01% |
73,000
| – | – |
2019 Q1
1 quarter
|
|
210
CALL
AudioCodes
AUDC
$277M
| $156K | 0.01% |
+10,100
| New | +$154K |
2019 Q2
0 quarters
|
|
|
GMDA
211
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
| $145K | 0.01% |
29,203
| – | – |
2018 Q4
2 quarters
|
|
|
FOMX
212
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $145K | 0.01% |
62,437
+11,741
| +23% | +$35.1K |
2019 Q1
1 quarter
|
|
213
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
| $139K | 0.01% |
2,394
-429
| -15% | -$25K |
2019 Q1
1 quarter
|
|
214
Indaptus Therapeutics
INDP
$385M
| $137K | 0.01% |
14
+5
| +56% | +$63.1K |
2019 Q1
1 quarter
|
|
215
BioLineRX
BLRX
$10.5M
| $134K | 0.01% |
625
+266
| +74% | +$59.7K |
2019 Q1
1 quarter
|
|
216
CALL
ADMA Biologics
ADMA
$2.5B
| $132K | 0.01% |
+34,000
| New | +$150K |
2019 Q2
0 quarters
|
|
|
217
ADMA Biologics
ADMA
$2.5B
| $129K | 0.01% |
34,034
-30,000
| -47% | -$132K |
2018 Q3
3 quarters
|
|
|
ARTX
218
DELISTED
Arotech Corporation
ARTX
| $115K | ﹤0.01% |
58,985
+6,587
| +13% | +$16.5K |
2019 Q1
1 quarter
|
|
219
Chemomab Therapeutics
CMMB
$8.79M
| $114K | ﹤0.01% |
408
| – | – |
2019 Q1
1 quarter
|
|
220
CALL
Allot
ALLT
$449M
| – | – |
-35,100
| Closed | -$224K | – |
|
221
Bank of America
BAC
$357B
| – | – |
-328,696
| Closed | -$9.06M | – |
|
222
Citizens Financial Group
CFG
$27B
| – | – |
-325,000
| Closed | -$10.5M | – |
|
223
DELISTED
Discover Financial Services
DFS
| – | – |
-96,000
| Closed | -$6.8M | – |
|
224
iShares MSCI South Korea ETF
EWY
$22.3B
| – | – |
-8,460
| Closed | -$513K | – |
|
225
DELISTED
Foot Locker
FL
| – | – |
-46,511
| Closed | -$2.8M | – |
|
Similar funds
LIC
Delek Group's Q2 2019 Portfolio in Review
As of Q2 2019, Delek Group held 255 positions worth $2.59B, up 7.5% from $2.41B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Delek Group's Q2 2019 filing shows 49 new, 70 increased, 72 reduced and 35 closed positions. Its largest new stake was Philip Morris: 340,000 shares worth $26.4M. The largest sale was iShares MSCI Emerging Markets ETF, an estimated $50.7M.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, up from 19% a quarter earlier, followed by Technology and Healthcare.
- Delek Group's largest Q2 2019 buy was Philip Morris: 340,000 shares worth $26.4M.
- Delek Group added most to iShares US Healthcare Providers ETF in Q2 2019, an estimated $28.1M increase.
- Delek Group's biggest Q2 2019 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $50.7M.
- Delek Group fully exited Southern Copper in Q2 2019, selling an estimated $19.3M.
- Delek Group's ten largest holdings make up 27% of its $2.59B portfolio in Q2 2019.
- Delek Group opened 49 new positions and closed 35 in Q2 2019.
- Delek Group's portfolio value rose 7.5% quarter-over-quarter to $2.59B.
Based on Delek Group's 13F filing for Q2 2019, filed 8 Aug 2019.